FDA approves the treatment of brain tumors with electrical fields
« Back to Article
NovoTTF-100A device & battery
NovoTTF-100A pads are placed onto the patient
The treatment delivers electric fields to a patient utilizing a portable, wearable device that permits the patient to maintain normal daily activities
The portable device weighs about six pounds (three kg) and is used continuously throughout the day by the patient
The NovoTTF treatment involves placing pads onto the patient's skin that creates a low intensity and alternating electric field within the tumor
Novocure uses "Tumor Treating Fields" (NovoTTF) to treat cancerous growths
NovoTTF is first ever FDA approved cancer treatment for patients as an alternative to chemotherapy
The electric field prevents the normal mitotic process and causes cancer cell death prior to division without harming healthy cells
Article Summary
The FDA (US Food and Drug Administration) has approved a new treatment for patients as an alternative to chemotherapy. The promising new non-invasive treatment by Novocure uses "Tumor Treating Fields" (NovoTTF) to treat cancerous growths and is now available for adult patients with recurring brain tumors (recurrent glioblastoma or GBM). The treatment delivers electric fields to a patient utilizing a portable, wearable device that permits the patient to maintain normal daily activities without down time.
« Back to FDA approves the treatment of brain tumors with electrical fields
Other Images from this Gallery
Related Articles
-
Targeted chemotherapy - fighting cancer without the side effects
14th September, 2009
-
Scientists destroy tumors in mice using light therapy
13th November, 2011
-
Researchers develop “cluster bomb” to target cancer
24th August, 2010
-
LED device could aid in cancer treatment
25th October, 2010
-
Painting brain tumors with nanoparticles may help defeat cancer
13th August, 2009
-
Stem cell elimination offers ovarian cancer breakthrough
5th February, 2010
